What lessons can be learned from γδ T cell-based cancer immunotherapy trials?
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
What lessons can be learned from γδ T cell-based cancer immunotherapy trials?
Authors
Keywords
-
Journal
Cellular & Molecular Immunology
Volume 10, Issue 1, Pages 35-41
Publisher
Springer Nature
Online
2012-12-17
DOI
10.1038/cmi.2012.39
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Questionable Relevance of T Lymphocytes in Renal Cell Carcinoma
- (2014) B. A. Inman et al. JOURNAL OF IMMUNOLOGY
- CD70 expression patterns in renal cell carcinoma
- (2012) Lucia B. Jilaveanu et al. HUMAN PATHOLOGY
- Human V 9V 2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts
- (2012) J. Gertner-Dardenne et al. JOURNAL OF IMMUNOLOGY
- Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy
- (2012) Volker Kunzmann et al. JOURNAL OF IMMUNOTHERAPY
- Harnessing γδ T cells in anticancer immunotherapy
- (2012) Dalil Hannani et al. TRENDS IN IMMUNOLOGY
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
- (2011) A J Nicol et al. BRITISH JOURNAL OF CANCER
- Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
- (2011) Madhavi Challa-Malladi et al. CANCER CELL
- Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
- (2011) Joshua M. Lang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- How tumors might withstand γδ T-cell attack
- (2011) Aude-Hélène Capietto et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Interindividual Variability of Response to Rituximab: From Biological Origins to Individualized Therapies
- (2011) G. Cartron et al. CLINICAL CANCER RESEARCH
- The gene expression profile of phosphoantigen-specific humanγδT lymphocytes is a blend of αβ T-cell and NK-cell signatures
- (2011) Fréderic Pont et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Stimulated T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer
- (2011) A.-H. Capietto et al. JOURNAL OF IMMUNOLOGY
- Adjuvant zoledronic acid for breast cancer: mechanism of action?
- (2011) Volker Kunzmann et al. LANCET ONCOLOGY
- Immune parameters affecting the efficacy of chemotherapeutic regimens
- (2011) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- PGE2 inhibits natural killer and γδ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling
- (2010) Ludovic Martinet et al. BIOCHEMICAL PHARMACOLOGY
- Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
- (2010) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Optimizing Tumor-Reactive γδT Cells for Antibody-Based Cancer Immunotherapy
- (2010) S. Meraviglia et al. CURRENT MOLECULAR MEDICINE
- Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors
- (2010) Atsutaka Noguchi et al. CYTOTHERAPY
- A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells☆☆☆
- (2010) Jun Nakajima et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Phosphoantigens Overcome Human TCRV 9+ Cell Immunosuppression by TGF- : Relevance for Cancer Immunotherapy
- (2010) A.-H. Capietto et al. JOURNAL OF IMMUNOLOGY
- V 9V 2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells
- (2010) M. D'Asaro et al. JOURNAL OF IMMUNOLOGY
- Zoledronate Stimulates γδ T Cells in Prostate Cancer Patients
- (2010) Michio Naoe et al. ONCOLOGY RESEARCH
- Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies
- (2009) J. Gertner-Dardenne et al. BLOOD
- Antitumor Activity of T Cells Reactive against Cytomegalovirus-Infected Cells in a Mouse Xenograft Tumor Model
- (2009) C. Devaud et al. CANCER RESEARCH
- A regulatory cross-talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells
- (2009) Ludovic Martinet et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
- (2009) Yu Abe et al. EXPERIMENTAL HEMATOLOGY
- γδ T cells as immune effectors against high-grade gliomas
- (2009) Lawrence S. Lamb IMMUNOLOGIC RESEARCH
- Pitfalls on the roadmap to γδ T cell-based cancer immunotherapies
- (2009) Ludovic Martinet et al. IMMUNOLOGY LETTERS
- Large scale expansion of Vγ9Vδ2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS “TCR γ/δ + T cell isolation kit”
- (2009) Samuel Salot et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Cutting Edge: TGF- 1 and IL-15 Induce FOXP3+ Regulatory T Cells in the Presence of Antigen Stimulation
- (2009) R. Casetti et al. JOURNAL OF IMMUNOLOGY
- Chemokine Receptors Expression and Migration Potential of Tumor-infiltrating and Peripheral-expanded Vγ9Vδ2 T Cells From Renal Cell Carcinoma Patients
- (2009) Emilie Viey et al. JOURNAL OF IMMUNOTHERAPY
- Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma
- (2009) Nichole L. Bryant et al. NEURO-ONCOLOGY
- Phosphoantigen-activated V 2V 2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection
- (2008) G. Gong et al. BLOOD
- Intravesical administration of γδ T cells successfully prevents the growth of bladder cancer in the murine model
- (2008) Takeshi Yuasa et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
- (2008) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Zoledronate facilitates large-scale ex vivo expansion of functional γδ T cells from cancer patients for use in adoptive immunotherapy*
- (2008) M. Kondo et al. CYTOTHERAPY
- Inhibition of phosphoantigen-mediated γδ T-cell proliferation by CD4+ CD25+ FoxP3+regulatory T cells
- (2008) Volker Kunzmann et al. IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now